We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Disease Modelling and Drug Discovery in Neurological Disorders

Video   Apr 29, 2016

 


About the Speaker
Zameel Cader Is Scientific Director of IMI StemBANCC and is the Director of the Oxford Headache Centre. He is also Clinical Director for Mental Health, Dementia and Neurology for the Strategic Clinical Network. He is Associate Professor in Clinical Neurosciences at the Nuffield Department of Clinical Neuroscience and the Weatherall Institute of Molecular Medicine. His research programme is focused on understanding the disease process in neurodysfunctional disorders such as migraine and neurodegenerative disorders such as Alzheimer's Disease using cell biology, model organism and human imaging studies. His group is now working with MRC Technology to bring more effective treatments arising from these findings to clinic.
AbstractThis presentation will focus on stemBANCC and its progress in developing disease relevant models as well as how we hope to turn these into drug screening assays.

 
 
 
Advertisement
 

Recommended Videos

Intelligent Intervention Into Multiple Sclerosis With Next-generation Therapies

Video

As scientists learn more about the underlying causes of multiple sclerosis, they are developing intelligent interventions that slow or halt the progression of the disease. Learn more about the creation of zanimod (Zeposia), the first disease-altering MS therapy.

WATCH NOW

Teach Me in 10 – Molecular and Cellular Multiplexing With Professor George Church

Video

In this instalment of Teach Me in 10, Professor George Church, a pioneer of genomics and synthetic biology, treats us to a topic that he hasn't actually presented on publicly before: molecular and cellular multiplexing.

WATCH NOW

Teach Me in 10 - CRISPR, Cell Therapies and Drug Discovery With Dr Theo Roth

Video

This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE